Double jeopardy: a patient's tale of two concurrent hypercalcaemic syndromes.
Aditi SharmaFatima BahowairathChukwuma UdukuJulia E OstbergPublished in: BMJ case reports (2020)
Primary hyperparathyroidism (PHPT) is the most common cause of parathyroid hormone (PTH) dependent hypercalcaemia, however there are few reported cases of its co-occurrence in patients with familial hypocalciuric hypercalcaemia (FHH). This case highlights the challenges in managing a rare case of dual pathology. A 49-year-old Caucasian woman with symptoms of hypercalcaemia presented with an adjusted serum calcium of 2.77 mmol/L and PTH of 11.5 pmol/L. Neck ultrasound and sestamibi scan were concordant with a left lower parathyroid adenoma, and a preoperative dual-energy X-ray absorptiometry scan confirmed osteopenia. Parathyroidectomy resulted in a PTH reduction from 11.5 pmol/L to 2.7 pmol/L. Interestingly, her lowest pre-operative adjusted serum calcium of 2.67 mmol/L remained unchanged 14 months post-parathyroidectomy. Twenty-four hours urine calcium:creatinine clearance ratio performed postoperatively was low and sequencing analysis of the calcium-sensing receptor gene confirmed the coexistence of FHH. Although surgery is not indicated in FHH, parathyroidectomy may help reduce hypercalcaemia and its associated complications if there is coexistent PHPT.
Keyphrases
- dual energy
- computed tomography
- rare case
- image quality
- magnetic resonance imaging
- case report
- minimally invasive
- contrast enhanced
- patients undergoing
- early onset
- single cell
- magnetic resonance
- copy number
- gene expression
- physical activity
- metabolic syndrome
- sleep quality
- uric acid
- bone mineral density
- radiation therapy
- transcription factor
- atrial fibrillation
- ultrasound guided